Wall Street Analysts See a 332.28% Upside in Adverum Biotechnologies (ADVM): Can the Stock Really Move This High?

Shares of Adverum Biotechnologies (ADVM) have gained 3.3% over the past four weeks to close the last trading session at $6.94, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$30 indicates a potential upside of 332.3%.The mean estimate comprises seven short-term price targets with a standard deviation of $11.02. While the lowest estimate of$12 indicates a 72.9% increase from th ...